Artelo Biosciences Analyst See It As An Emerging Biotech

benzinga.com/analyst-stock-ratings/upgrades/25/07/46306400/artelo-biosciences-analyst-see-it-as-an-emerging-biotech

D. Boral Capital upgraded Artelo Biosciences, Inc. (NASDAQ:ARTL) on Tuesday.
The analyst upgraded from Hold to Buy and introduced a price forecast of $20.
Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and…

This story appeared on benzinga.com, 2025-07-08 19:06:00.
The Entire Business World on a Single Page. Free to Use →